Pharma Equity Group A/S
PEG.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | DKK 203 | DKK 465 | DKK 15 | DKK 23 |
| - Cash | DKK 2 | DKK 4 | DKK 0 | DKK 0 |
| + Debt | DKK 11 | DKK 30 | DKK 23 | DKK 19 |
| Enterprise Value | DKK 212 | DKK 491 | DKK 38 | DKK 42 |
| Revenue | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Gross Profit | -DKK 0 | -DKK 0 | DKK 0 | DKK 0 |
| % Margin | – | – | – | – |
| EBITDA | -DKK 21 | -DKK 25 | DKK 4 | DKK 6 |
| % Margin | – | – | – | – |
| Net Income | -DKK 24 | -DKK 25 | DKK 3 | DKK 5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.023 | -0.023 | 0.078 | 0.097 |
| % Growth | -0.4% | -129.1% | -19.2% | – |
| Operating Cash Flow | -DKK 23 | -DKK 17 | -DKK 3 | -DKK 2 |
| Capital Expenditures | DKK 0 | -DKK 0 | DKK 0 | DKK 0 |
| Free Cash Flow | -DKK 23 | -DKK 17 | -DKK 3 | -DKK 2 |